Furosemide
- Product NDC
- 71610-636
- 11-digit product format
- 716100636
- Labeler code
- 71610
- Product ID
- 71610-636_e9231c86-1596-42eb-b1f8-61747c75f030
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- furosemide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA076796
- Marketing category
- ANDA
- Marketing start
- 2022-01-04
- Substance
- FUROSEMIDE
- Active strength
- 80 mg/1
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
openFDA Listing Details
- Product ID
- 71610-636_e9231c86-1596-42eb-b1f8-61747c75f030
- SPL ID
- e9231c86-1596-42eb-b1f8-61747c75f030
- Product type
- HUMAN PRESCRIPTION DRUG
- Finished product
- Yes
- Brand name base
- Furosemide
- Generic name
- furosemide
- Dosage form
- TABLET
- Route
- ORAL
- Marketing start
- 2022-01-04
- Marketing category
- ANDA
- Application number
- ANDA076796
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]
- Listing expiration
- 2026-12-31
openFDA Active Ingredients
| Ingredient | Strength |
|---|
| FUROSEMIDE | 80 mg/1 |
openFDA Harmonized Identifiers
| Field | Values |
|---|
| Unii | 7LXU5N7ZO5 |
| Rxcui | 197732, 310429, 313988 |
| Spl Set Id | 6f124d7d-a19d-4de6-8ea4-719a42eb520b |
| Manufacturer Name | Aphena Pharma Solutions - Tennessee, LLC |
openFDA Package Details
| Package NDC | Description | Marketing start | Sample |
|---|
| 71610-636-30 | 30 TABLET in 1 BOTTLE (71610-636-30) | 2022-02-24 | No |
| 71610-636-45 | 45 TABLET in 1 BOTTLE (71610-636-45) | 2022-02-24 | No |
| 71610-636-53 | 60 TABLET in 1 BOTTLE (71610-636-53) | 2022-02-24 | No |
| 71610-636-60 | 90 TABLET in 1 BOTTLE (71610-636-60) | 2022-02-24 | No |
| 71610-636-80 | 180 TABLET in 1 BOTTLE (71610-636-80) | 2022-02-24 | No |
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 7LXU5N7ZO5 | FUROSEMIDE | 54-31-9 | FUROSEMIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-636-30 | 71610063630 | 30 TABLET in 1 BOTTLE (71610-636-30) | 30 tablet | 2022-02-24 | No | No | Historical |
| 71610-636-45 | 71610063645 | 45 TABLET in 1 BOTTLE (71610-636-45) | 45 tablet | 2022-02-24 | No | No | Historical |
| 71610-636-53 | 71610063653 | 60 TABLET in 1 BOTTLE (71610-636-53) | 60 tablet | 2022-02-24 | No | No | Historical |
| 71610-636-60 | 71610063660 | 90 TABLET in 1 BOTTLE (71610-636-60) | 90 tablet | 2022-02-24 | No | No | Historical |
| 71610-636-80 | 71610063680 | 180 TABLET in 1 BOTTLE (71610-636-80) | 180 tablet | 2022-02-24 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| FUROSEMIDE TABLETS, USP | Aphena Pharma Solutions - Tennessee, LLC | 2022-03-10 | HUMAN PRESCRIPTION DRUG LABEL | 2 |